top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Killing Cancer : Discovery and Selection of New Target Molecules
Killing Cancer : Discovery and Selection of New Target Molecules
Autore Kallunki Tuula
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (302 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato ferlin
myoferlin
dysferlin
otoferlin
C2 domain
plasma membrane
sulconazole
NF-κB
IL-8
mammosphere
breast cancer stem cells
AF1Q
MLLT11
WNT
STAT
esophageal cancer
prognosis
mTORC1
mTORC2
metabolism
rapalogs
mTOR inhibitors
cancer metabolism
mTOR in immunotherapy
nutrient metabolism
kinase inhibitors
mTOR signaling
MAPK kinase
ERK1
ERK2
CD domain
Rolled
SCH772984
VRT-11E
sevenmaker
cancer therapy
EMT
lysosome
lysosome-mediated invasion
MZF1
phosphorylation
PAK4
SUMOylation
transcription factor
zinc finger
glucocorticoids
3D growth
nuclear factor kappa-light-chain-enhancer of activated B-cells (NF-κB)
epithelial-mesenchymal transition
anoikis
proliferation
targeted cancer therapy
disulfiram
NPL4
replication stress
DNA damage
BRCA1
BRCA2
ATR pathway
PDAC
TCIRG1
ATP6V0a3
invasion
migration
matrix degradation
pH-regulation
autophagy
multidrug resistance in cancer
drug efflux pumps
ATP-binding cassette transporter
breast cancer resistance protein (BCRP)
ABCG2
pyrazolo-pyrimidine derivative
SCO-201
colorectal cancer
immunotherapy
inflammation
microsatellite instability
oncofetal chondroitin sulfate
chondroitin sulfate
cancer
solid tumors
target
pediatric cancer
VAR2
dexamethasone
thyroid cancer
microgravity
space environment
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Killing Cancer
Record Nr. UNINA-9910557648103321
Kallunki Tuula  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Proteases—From Basic Structure to Function to Drug Design as Targeted Therapy
Proteases—From Basic Structure to Function to Drug Design as Targeted Therapy
Autore Kwok Hang Fai
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (93 p.)
Soggetto topico Research & information: general
Soggetto non controllato MMP
MMP2
MMP9
MMP7
MMP14
matrix metalloproteases
PDAC
pancreatic cancer
Bowman–Birk inhibitor
ranacyclin
trypsin inhibitor
structure–activity relationship
synergistic effect
Gentamicin
matrix metalloproteinase
extracellular matrix
nuclei
cancer
apoptosis
immune response
cysteine protease inhibitor
stefin
signal peptide
parasite
phylogenetic analysis
diversification
protein structure
vascular endothelial growth factors (VEGFs)
VEGF-A
PlGF
VEGF-B
VEGF-C
VEGF-D
angiogenesis
lymphangiogenesis
CCBE1
proteases
ADAMTS3
plasmin
cathepsin D
KLK3
prostate-specific antigen (PSA)
thrombin
wound healing
metastasis
proteolytic activation
vascular biology
lymphedema
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557353103321
Kwok Hang Fai  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Role of Medical Imaging in Cancers . Volume 1
Role of Medical Imaging in Cancers . Volume 1
Autore Fanti Stefano
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (312 pages)
Soggetto topico Medicine
Soggetto non controllato positron emission tomography
head and neck neoplasms
neovascularization
pathologic
PET/CT
urothelial carcinoma
bladder cancer
upper tract urothelial carcinoma
survival
PET
PSMA
prostate
DCFPyL
DCFBC
PSMA-1007
ovarian cancer
relapse
SUVmax
targeted therapy
prognosis
soft tissue sarcoma (STS)
pazopanib
dynamic 18F-FDG PET/CT
SUV
two-tissue compartment model
magnetic resonance imaging
machine learning
diffusion
perfusion
texture analysis
squamous cell carcinoma of the head and neck
diffusion-weighted imaging
malignant pleural mesothelioma
pleural dissemination
empyema
pleural effusion
mCRPC
SPECT/CT
Computer-assisted diagnosis
XOFIGO
Therapy response assessment
circulating miRNAs
breast cancer
imaging parameters
PET/MRI
biomarkers
triple negative breast cancer
VCAM-1
SPECT imaging
sdAbs
Hounsfield unit
computed tomography
adipose tissue
precision oncology
FDG-PET/CT
PERCIST
metastatic breast cancer
prostate cancer
18F-FACBC
recurrence
meta-analysis
review
meningioma
somatostatin receptor
neuroimaging
radionuclide therapy
breast
imaging
marker
radiomics
Yin Yang 1
PDAC
Mesothelin
noninvasive imaging
receptor status
molecular imaging
nuclear medicine
guidelines
overutilization
epistemology
consensus
mantle cell lymphoma
18F-FDG PET/CT
Deauville criteria
Radium-223
FDG
castrate resistant prostate cancer
programmed cell death 1 receptor
diagnostic imaging
CTLA-4 Antigen
Immunotherapy
Adoptive
radioactive tracers
radionuclide imaging
CD8-Positive T-Lymphocytes
PI-RADS
diffusion kurtosis imaging
dynamic contrast-enhanced magnetic resonance imaging
68Gallium-PSMA PET/CT
prostate-specific-antigen
PSA kinetics thresholds
biochemical recurrence
optimal cutoff level
non-small-cell lung cancer
circulating tumor cells
immunotherapy
response to treatment
head and neck cancer
HPV
EBV
p16
Molecular imaging
miRNA expression
radiogenomics
radiomic
diagnosis
biomarker
glioblastoma
radiation therapy
MRI
diffusion tensor imaging
Hodgkin lymphoma
diffuse large B-cell lymphoma
staging
response assessment
locally advanced cervical cancer
concurrent chemoradiotherapy
treatment response
follow up
cystic tumor
International Consensus Guidelines
intraductal papillary mucinous neoplasms
pancreatic neoplasms
PD-1
PD-L1
response to therapy
NSCLC
positron-emission tomography
single-photon emission computed tomography
immune checkpoint inhibitors
gold nanoparticle
heat shock protein 70
spectral-CT
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557432103321
Fanti Stefano  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Role of Medical Imaging in Cancers . Volume 2
Role of Medical Imaging in Cancers . Volume 2
Autore Fanti Stefano
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (228 p.)
Soggetto topico Medicine
Soggetto non controllato positron emission tomography
head and neck neoplasms
neovascularization
pathologic
PET/CT
urothelial carcinoma
bladder cancer
upper tract urothelial carcinoma
survival
PET
PSMA
prostate
DCFPyL
DCFBC
PSMA-1007
ovarian cancer
relapse
SUVmax
targeted therapy
prognosis
soft tissue sarcoma (STS)
pazopanib
dynamic 18F-FDG PET/CT
SUV
two-tissue compartment model
magnetic resonance imaging
machine learning
diffusion
perfusion
texture analysis
squamous cell carcinoma of the head and neck
diffusion-weighted imaging
malignant pleural mesothelioma
pleural dissemination
empyema
pleural effusion
mCRPC
SPECT/CT
Computer-assisted diagnosis
XOFIGO
Therapy response assessment
circulating miRNAs
breast cancer
imaging parameters
PET/MRI
biomarkers
triple negative breast cancer
VCAM-1
SPECT imaging
sdAbs
Hounsfield unit
computed tomography
adipose tissue
precision oncology
FDG-PET/CT
PERCIST
metastatic breast cancer
prostate cancer
18F-FACBC
recurrence
meta-analysis
review
meningioma
somatostatin receptor
neuroimaging
radionuclide therapy
breast
imaging
marker
radiomics
Yin Yang 1
PDAC
Mesothelin
noninvasive imaging
receptor status
molecular imaging
nuclear medicine
guidelines
overutilization
epistemology
consensus
mantle cell lymphoma
18F-FDG PET/CT
Deauville criteria
Radium-223
FDG
castrate resistant prostate cancer
programmed cell death 1 receptor
diagnostic imaging
CTLA-4 Antigen
Immunotherapy
Adoptive
radioactive tracers
radionuclide imaging
CD8-Positive T-Lymphocytes
PI-RADS
diffusion kurtosis imaging
dynamic contrast-enhanced magnetic resonance imaging
68Gallium-PSMA PET/CT
prostate-specific-antigen
PSA kinetics thresholds
biochemical recurrence
optimal cutoff level
non-small-cell lung cancer
circulating tumor cells
immunotherapy
response to treatment
head and neck cancer
HPV
EBV
p16
Molecular imaging
miRNA expression
radiogenomics
radiomic
diagnosis
biomarker
glioblastoma
radiation therapy
MRI
diffusion tensor imaging
Hodgkin lymphoma
diffuse large B-cell lymphoma
staging
response assessment
locally advanced cervical cancer
concurrent chemoradiotherapy
treatment response
follow up
cystic tumor
International Consensus Guidelines
intraductal papillary mucinous neoplasms
pancreatic neoplasms
PD-1
PD-L1
response to therapy
NSCLC
positron-emission tomography
single-photon emission computed tomography
immune checkpoint inhibitors
gold nanoparticle
heat shock protein 70
spectral-CT
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557309503321
Fanti Stefano  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui